Zantac pulled off shelves due to cancer scare; The end of the road for Motif Bio
→ GSK is recalling its heartburn medicine Zantac, sold generically as ranitidine, from all markets after the FDA found it contains “‘unacceptable’ levels of …
Sign up to read this article for free.
Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.
